First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan.

about

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan.

Item

http://www.wikidata.org/entity/Q48154249

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

First-Line Helicobacter pylori ...... nic Kidney Diseases in Taiwan.

@en

First-Line Helicobacter pylori ...... nic Kidney Diseases in Taiwan.

@nl

type

Item

label

First-Line Helicobacter pylori ...... nic Kidney Diseases in Taiwan.

@en

First-Line Helicobacter pylori ...... nic Kidney Diseases in Taiwan.

@nl

prefLabel

First-Line Helicobacter pylori ...... nic Kidney Diseases in Taiwan.

@en

First-Line Helicobacter pylori ...... nic Kidney Diseases in Taiwan.

@nl

P1476

First-Line Helicobacter pylori ...... onic Kidney Diseases in Taiwan

@en

P2093

Cheng-En Tsai

http://www.w3.org/2001/XMLSchema#string

Chien-Hua Chiu

http://www.w3.org/2001/XMLSchema#string

Chih-Chien Yao

http://www.w3.org/2001/XMLSchema#string

Chih-Fang Huang

http://www.w3.org/2001/XMLSchema#string

Chung-Mou Kuo

http://www.w3.org/2001/XMLSchema#string

Hsing-Ming Wang

http://www.w3.org/2001/XMLSchema#string

Kai-Lung Tsai

http://www.w3.org/2001/XMLSchema#string

Keng-Liang Wu

http://www.w3.org/2001/XMLSchema#string

Wei-Chen Tai

http://www.w3.org/2001/XMLSchema#string

P2860

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.

Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.

US Renal Data System 2010 Annual Data Report.

Clinical pharmacokinetics of clarithromycin.

Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease.

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.

A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases.

A new look at anti-Helicobacter pylori therapy

P304

3762194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/3762194

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29376072

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

5742431

http://www.w3.org/2001/XMLSchema#string